airway
epitheli
barrier
function
front
line
host
defens
airborn
threat
integr
barrier
essenti
regul
innat
immun
lung
barrier
integr
known
disrupt
number
environment
stimuli
barrier
properti
airway
epithelium
primarili
determin
apic
junction
complex
ajc
compos
tight
junction
tj
adheren
junction
aj
shown
ajc
regul
structur
integr
tissu
also
select
paracellular
permeabl
cellular
differenti
migrat
signal
transduct
recent
genomewid
associ
studi
uncov
link
gene
polymorph
sever
junction
protein
protocadherin
gene
encod
cadherinrel
famili
member
asthma
well
increas
risk
sever
viral
infect
virus
respons
major
respiratori
ill
children
mount
evid
indic
increas
permeabl
airway
epitheli
barrier
common
manifest
lower
respiratori
tract
viral
infect
may
significantli
contribut
develop
mucos
inflamm
find
highlight
import
studi
effect
viral
infect
structur
function
airway
epitheli
barrier
respiratori
syncyti
viru
rsv
common
respiratori
viru
caus
lower
respiratori
tract
infect
inflamm
histor
consid
pediatr
diseas
rsv
infect
recogn
import
sourc
morbid
mortal
elderli
highrisk
adult
investig
cell
cultur
anim
model
shown
longterm
inflamm
postrsv
infect
addit
human
studi
shown
strong
associ
rsv
persist
wheez
childhood
asthma
despit
extens
research
current
treatment
strategi
rsv
larg
support
palivizumab
monoclon
antibodi
approv
rsv
prophylaxi
highrisk
infant
moder
decreas
hospit
admiss
due
rsv
infect
pathogen
mechan
rsv
infect
remain
poorli
understood
specif
littl
known
effect
rsv
structur
function
airway
epitheli
barrier
previou
studi
demonstr
rsv
infect
increas
permeabl
cultur
bronchial
epitheli
cell
monolay
trigger
protein
kinas
ddepend
tj
disassembl
other
show
differ
epitheli
barrier
dysfunct
could
significantli
acceler
rsvinduc
airway
inflamm
import
understand
cellular
mechan
either
attenu
disassembl
promot
recoveri
airway
epitheli
ajc
viral
infect
cyclic
adenosin
monophosph
camp
import
second
messeng
requir
mani
critic
homeostat
cellular
function
camp
known
activ
two
major
signal
mechan
one
involv
protein
kinas
pka
involv
epac
guaninenucleotid
exchang
factor
small
gtpase
effect
camp
signal
intercellular
junction
extens
studi
vascular
endothelium
studi
demonstr
elev
camp
level
endotheli
cell
could
either
barrierprotect
barrierdisrupt
effect
depend
extern
stimuli
intracellular
site
camp
accumul
forskolin
produc
indian
coleu
forskoliii
plant
known
activ
adenyl
cyclas
increas
level
intracellular
camp
efficaci
oral
forskolin
asthma
prophylaxi
trial
two
small
singlecent
studi
found
reduc
asthma
attack
thought
act
camp
smooth
muscl
relax
howev
neither
studi
report
advers
effect
includ
tachycardia
lower
blood
pressur
increas
risk
bleed
interact
gluconeogenesi
studi
effect
camp
signal
airway
epitheli
cell
importantli
effect
camp
signal
rsvinfect
epithelium
investig
goal
studi
test
hypothesi
elev
camp
level
could
prevent
ajc
disrupt
increas
permeabl
caus
rsv
infect
model
airway
epitheli
cell
monolay
report
barrierprotect
role
camp
infect
epitheli
cell
involv
multipl
mechan
stabil
aj
tj
structur
attenu
rsvinduc
rearrang
cortic
cytoskeleton
inhibit
viral
propag
follow
primari
monoclon
antibodi
mab
polyclon
antibodi
pab
use
detect
junction
signal
protein
immunofluoresc
label
immunoblot
antioccludin
mab
thermofish
scientif
waltham
mab
bd
bioscienc
san
jose
ca
anticlaudin
pab
abcam
cambridg
uk
anticortactin
mab
clone
emd
millipor
billerica
anticortactin
pab
antiphosphocreb
rabbit
mab
anticreb
rabbit
mab
cell
signal
technolog
danver
antigapdh
mab
abcam
cambridg
fluoresc
label
phalloidin
thermofish
scientif
use
visual
actin
filament
antirabbit
antimous
secondari
antibodi
conjug
dye
obtain
thermofish
scientif
mous
rabbit
secondari
hrpconjug
antibodi
purchas
ge
healthcar
pittsburgh
pa
forskolin
obtain
sigmaaldrich
st
loui
mo
purchas
tocri
bioscienc
bristol
uk
highmolecularweight
polyi
c
purchas
invivogen
san
diego
ca
fluoresceinconjug
dextran
obtain
thermofish
scientif
human
bronchial
epitheli
cell
gift
dr
dieter
c
gruenert
univers
california
san
francisco
cultur
collagenco
transwel
plastic
plate
previous
describ
primari
normal
human
bronchial
epitheli
nhbe
lonza
basal
switzerland
cell
normal
diseas
donor
expand
passag
cell
trypsin
seed
collagen
coat
insert
grown
defin
media
gentamicin
amphotericin
b
penstrep
ad
dulbecco
minim
essenti
medium
dmem
ham
differenti
airliquid
interfac
evid
complet
dri
apic
surfac
transepitheli
electr
resist
greater
surfac
area
observ
ciliari
movement
mucu
product
wildtyp
rsv
strain
rsv
stock
grown
previous
describ
polar
human
airway
epitheli
cell
infect
apic
rsv
dilut
dmem
multipl
infect
moi
control
cell
monolay
receiv
dmem
alon
experi
use
rsv
deriv
rsv
express
green
fluoresc
protein
gene
kind
gift
dr
mark
peepl
nationwid
children
hospit
research
institut
columbu
oh
peter
collin
nation
institut
health
bethesda
md
describ
previous
epitheli
permeabl
small
ion
evalu
transepitheli
electr
resist
teer
measur
normal
rsvinfect
cell
monolay
use
evomx
voltohmmet
world
precis
instrument
sarasota
fl
welldifferenti
cell
monolay
teer
x
use
experi
present
data
calcul
percent
chang
compar
either
vehicletr
control
time
zero
viral
infect
epitheli
permeabl
larger
molecul
evalu
measur
transmonolay
flux
fluorescein
isothiocyan
fitc
conjug
dextran
kda
invitrogen
previous
describ
briefli
epitheli
cell
monolay
grow
transwel
filter
apic
expos
mgml
fitclabel
dextran
phosphatebuff
salin
pb
minut
incub
pb
sampl
collect
lower
chamber
fitc
fluoresc
intens
measur
use
flexstat
plate
reader
molecular
devic
sunnyval
ca
excit
emiss
wavelength
nm
respect
valu
dextranfre
pb
subtract
measur
concentr
fitcdextran
calcul
use
prism
softwar
graphpad
la
jolla
ca
base
plot
standard
curv
prepar
via
serial
dilut
stock
solut
fitclabel
dextran
pb
epitheli
cell
monolay
grown
transwel
insert
subject
differ
fixat
protocol
label
ajc
protein
cortactin
cell
fix
either
cold
methanol
ethanol
respect
visual
actin
filament
creb
protein
cell
fix
neutralbuff
paraformaldehyd
pfa
subsequ
permeabil
fix
cell
incub
specif
primari
antibodi
follow
incub
alexa
fluorlabel
secondari
antibodi
nuclei
stain
dapi
sigmaaldrich
immunofluorescentlylabel
cell
monolay
examin
use
olympu
fluoview
confoc
microscop
olympu
america
center
valley
pa
u
plan
apo
na
oil
object
alexa
fluor
signal
imag
sequenti
frameinterlac
mode
elimin
cross
talk
channel
imag
process
use
olympu
viewer
softwar
adob
photoshop
imag
shown
repres
least
independ
experi
multipl
imag
taken
per
slide
indic
treatment
cell
monolay
cell
cultur
plate
cell
wash
cold
pb
lyse
ripa
buffer
santa
cruz
biotechnolog
dalla
tx
protein
concentr
quantifi
bicinchonin
acid
bca
protein
assay
pierc
thermo
scientif
waltham
equal
concentr
protein
sampl
resolv
sdspage
transfer
pvdf
membran
biorad
hercul
ca
membran
block
nonfat
dri
milk
case
phosphor
antibodi
bovin
serum
albumin
bsa
probe
primari
antibodi
overnight
follow
secondari
antibodi
membran
expos
ecl
ge
healthcar
protein
band
detect
use
xray
film
gapdh
use
lane
protein
load
control
total
rna
extract
pretreat
monolay
cellcultur
plate
use
ezna
total
rna
kit
omega
biotek
norcross
ga
addit
dnase
digest
omega
cdna
synthes
use
qscript
cdna
synthesi
kit
quanta
bioscienc
gaithersburg
md
amplifi
realtim
pcr
multicolor
realtim
pcr
detect
system
biorad
use
sybr
green
fastmix
quanta
bioscienc
primer
target
bp
sequenc
rsv
strain
genom
encod
viral
fusion
f
protein
caccctgttggaaac
ctctgtcagttcttg
sigmaaldrich
transcript
express
normal
use
glyceraldehyd
dehydrogenas
gapdh
housekeep
gene
rel
chang
gene
express
calcul
use
formula
chang
treat
sampl
control
sampl
ct
detect
gene
ct
gapdh
ct
threshold
number
intracellular
camp
concentr
clarifi
lysat
determin
use
catchpoint
camp
kit
molecular
devic
sunnyval
ca
per
manufactur
instruct
data
analyz
use
prism
softwar
graphpad
san
diego
ca
microsoft
excel
data
repres
three
experi
present
mean
sem
data
evalu
statist
anova
student
ttest
bonferroni
correct
multipl
comparison
signific
consid
p
valu
less
test
hypothesi
increas
intracellular
camp
level
could
protect
epitheli
barrier
disrupt
caus
rsv
infect
polar
airway
epitheli
cell
infect
rsv
strain
moi
presenc
absenc
forskolin
known
activ
adenylyl
cyclas
respons
camp
product
agreement
previous
publish
data
rsv
caus
mark
decreas
teer
h
viral
infect
fig
therebi
indic
disrupt
epitheli
barrier
two
differ
concentr
forskolin
consist
attenu
rsvinduc
barrier
breakdown
base
result
forskolin
concentr
chosen
subsequ
experi
order
examin
forskolindepend
preserv
epitheli
barrier
mediat
effect
ajc
next
visual
tj
organ
control
rsvinfect
epitheli
cell
monolay
immunofluoresc
label
essenti
tj
protein
zonula
occluden
zo
demonstr
normal
chicken
wire
tj
pattern
control
cell
monolay
fig
arrow
pattern
significantli
disrupt
h
rsv
infect
reflect
tj
fusion
format
multicellular
syncytia
fig
thick
arrowhead
along
intracellular
accumul
fig
thin
arrowhead
incub
forskolin
h
affect
label
control
epitheli
cell
monolay
prevent
rsvinduc
alter
label
fig
togeth
data
indic
forskolin
attenu
disrupt
tj
structur
increas
paracellular
permeabl
bronchial
epitheli
cell
caus
rsv
infect
cell
shown
exhibit
welldefin
ajc
appear
morpholog
similar
airway
epitheli
cell
vitro
ensur
physiolog
relev
result
obtain
immort
bronchial
epitheli
cell
also
use
primari
normal
human
bronchial
epitheli
nhbe
cell
cultur
airliquid
interfac
differenti
mucociliari
phenotyp
nhbe
cell
monolay
infect
apic
rsv
h
presenc
absenc
forskolin
airliquid
condit
nhbe
cell
form
tight
junction
fig
arrow
similar
cell
rsv
induc
substanti
tj
disassembl
nhbe
cell
manifest
disrupt
label
fig
thin
arrowhead
syncytia
format
thick
arrowhead
junction
disrupt
complet
prevent
forskolin
treatment
fig
cell
exhibit
similar
respons
rsv
infect
differenti
human
primari
cell
util
subsequ
experi
given
fact
forskolin
potent
inductor
camp
product
next
examin
whether
protect
effect
forskolin
airway
epithelium
associ
increas
intracellular
camp
polar
bronchial
epitheli
cell
infect
rsv
moi
vari
length
time
h
follow
stimul
forskolin
minut
test
time
intracellular
camp
increas
fold
baselin
minut
ad
forskolin
rsvinfect
cell
cultur
fig
note
mockinfect
cultur
similar
camp
level
rsv
infect
cell
rsv
infect
alon
alter
baselin
intracellular
camp
level
fig
sinc
observ
barrierstabil
effect
forskolin
correl
increas
product
camp
sought
determin
camp
analog
could
also
play
protect
role
rsvinfect
cell
monolay
furthermor
ask
forskolin
campdepend
stabil
airway
epitheli
barrier
involv
activ
major
effector
molecul
epac
order
answer
question
use
cellperm
camp
analog
resist
degrad
phosphodiesteras
cellperm
select
activ
epac
doserespons
studi
demonstr
consist
attenu
rsvinduc
drop
teer
bronchial
epitheli
cell
monolay
fig
contrast
concentr
known
effici
activ
epac
fail
prevent
rsvinduc
reduct
teer
fig
note
neither
compound
toxic
cell
base
ldh
releas
assay
data
shown
similar
forskolin
affect
integr
tj
control
bronchial
epitheli
cell
monolay
fig
h
rsv
infect
addit
markedli
attenu
disrupt
tj
occludin
aj
ecadherin
therebi
mimick
ajcprotect
effect
forskolin
fig
contrast
cell
exposur
fail
attenu
rsvinduc
ajc
disassembl
fig
microscopi
data
confirm
function
studi
forskolin
attenu
rsvinduc
drop
teer
increas
transepitheli
dextran
flux
wherea
ineffect
fig
claudin
integr
membran
protein
known
compon
tj
strand
interact
transmembran
tj
protein
essenti
tj
stabil
consist
report
effect
aj
tj
protein
junction
local
claudin
disrupt
rsv
infect
forskolin
attenu
rsvinduc
misloc
claudin
claudin
bronchial
epitheli
cell
collect
result
suggest
forskolininduc
elev
intracellular
camp
attenu
rsvinduc
disrupt
model
airway
epitheli
barrier
epacindepend
fashion
lack
barrierprotect
effect
pharmacolog
epac
activ
suggest
forskolin
camp
attenu
effect
rsv
epitheli
junction
activ
pka
test
suggest
measur
effect
forskolin
phosphoryl
activ
nuclear
transloc
creb
camp
respons
elementbind
protein
known
direct
substrat
pka
polar
bronchial
epitheli
cell
monolay
infect
rsv
moi
h
follow
stimul
forskolin
minut
express
local
phosphoryl
p
total
creb
examin
immunoblot
immunofluoresc
label
confoc
microscopi
lower
proport
nuclei
exhibit
posit
label
pcreb
vehicletr
control
compar
forskolinexpos
cell
indic
activ
pka
treatment
fig
furthermor
forskolin
treatment
increas
amount
pcreb
total
creb
total
cell
lysat
obtain
either
control
rsvinfect
epitheli
cell
fig
interestingli
select
pka
inhibitor
significantli
block
forskolininduc
phosphoryl
nuclear
transloc
creb
fig
therebi
provid
addit
evid
pka
activ
forskolintr
bronchial
epitheli
cell
attenu
phosphoryl
creb
sought
investig
whether
abl
attenu
protect
effect
forskolin
airway
barrier
polar
bronchial
epitheli
cell
monolay
infect
rsv
moi
h
presenc
absenc
forskolin
cell
treat
forskolin
fail
attenu
rsvinduc
ajc
disassembl
fig
infecti
cycl
rsv
consist
attach
entri
host
cell
transcript
replic
assembl
releas
new
viral
particl
viral
entri
epitheli
cell
rsv
f
protein
mediat
fusion
viru
cell
membran
subsequ
celltocel
spread
fusion
neighbor
cell
membran
result
format
syncytia
sinc
forskolin
decreas
rsvinduc
syncytia
format
hypothes
elev
intracellular
camp
downstream
signal
effector
might
decreas
rsv
f
mrna
titer
test
possibl
bronchial
epitheli
monolay
infect
rsv
moi
presenc
absenc
forskolin
camp
analog
express
viral
bp
sequenc
encod
f
protein
quantifi
realtim
pcr
found
express
rsv
f
mrna
significantli
decreas
epitheli
cell
pretreat
either
forskolin
affect
rsv
f
express
fig
parallel
experi
cell
infect
rgrsv
rsv
deriv
rsv
express
green
fluoresc
protein
gene
follow
numer
gfpposit
cell
entir
monolay
h
post
infect
cell
infect
rgrsv
cotreat
forskolin
yield
fewer
gfpposit
cell
fig
thu
along
pka
preserv
ajc
structur
function
result
suggest
increas
camp
level
inhibit
mrna
express
f
protein
attenu
viral
spread
airway
epitheli
cell
monolay
gain
addit
insight
effect
elev
camp
viral
infect
infect
cell
rsv
moi
subsequ
addit
forskolin
differ
time
follow
viral
inocul
h
immunofluoresc
label
confoc
microscopi
indic
forskolin
inhibit
rsvinduc
disrupt
ajc
structur
ad
rsv
inocul
fig
interestingli
protect
effect
forskolin
organ
epitheli
tj
aj
evid
even
campelev
agent
ad
late
h
begin
viral
infect
fig
arrow
likewis
therapeut
mode
forskolin
addit
attenu
rsvdepend
increas
transepitheli
dextran
flux
fig
inhibit
mrna
express
rsv
f
protein
fig
result
obtain
studi
emphas
two
differ
effect
increas
camp
level
rsvinfect
airway
epitheli
cell
one
effect
attenu
virusinduc
barrier
breakdown
ajc
disassembl
effect
inhibit
rsv
f
mrna
express
viral
propag
within
epitheli
monolay
creat
import
question
whether
describ
barrierprotect
effect
camp
repres
independ
mechan
strictli
secondari
effect
inhibit
viral
propag
answer
question
util
synthet
nonrepl
doublestrand
rna
viral
mimic
dsrna
polyinosin
polycytidyl
acid
polyi
c
agreement
previou
studi
polyi
c
treatment
airway
epitheli
cell
monolay
dramat
increas
epitheli
permeabl
fig
caus
tj
aj
disassembl
fig
short
arrow
effect
mimick
barrierdisrupt
consequ
rsv
infect
describ
structur
function
defect
ajc
polyi
ctreat
airway
epitheli
cell
significantli
attenu
forskolin
treatment
fig
result
indic
camp
attenu
epitheli
barrier
dysfunct
caus
viral
product
mechan
independ
inhibit
viral
replic
integr
permeabl
differ
epitheli
barrier
regul
perijunct
actin
cytoskeleton
previou
studi
demonstr
rsv
infect
disrupt
actin
cytoskeleton
airway
epitheli
cell
monolay
therefor
next
ask
whether
observ
barrierprotect
effect
camp
associ
alter
remodel
junctionassoci
filament
f
actin
fluoresc
label
use
visual
factin
essenti
actin
bind
protein
cortactin
control
rsvinfect
cell
monolay
control
epitheli
cell
demonstr
assembl
promin
circumferenti
factin
belt
level
ajc
fig
arrow
cortactin
weakli
label
belt
demonstr
addit
apic
label
rsv
infect
caus
dramat
cytoskelet
rearrang
manifest
increas
accumul
diffus
actin
filament
apic
region
cell
especi
area
form
syncytia
fig
arrowhead
cortactin
appear
accumul
promin
apic
factin
structur
interestingli
forskolin
littl
effect
normal
cytoskeleton
complet
prevent
factin
remodel
cortactin
transloc
rsvinfect
epitheli
cell
fig
arrow
result
demonstr
observ
barrierprotect
action
camp
could
mediat
inhibit
cytoskelet
rearrang
rsvinfect
epitheli
cell
monolay
emerg
evid
indic
critic
role
airway
epitheli
barrier
regul
respons
environment
stimuli
allergen
viral
infect
rsv
infect
caus
airway
inflamm
disrupt
epitheli
barrier
causal
connect
barrier
dysfunct
propag
mucos
inflamm
yet
establish
present
studi
describ
previous
unanticip
pharmacolog
approach
stabil
airway
epitheli
barrier
limit
rsv
infect
vitro
approach
involv
increas
intracellular
camp
level
either
appli
pharmacolog
adenylyl
cyclas
activ
forskolin
use
stabl
cellperm
analog
camp
increas
camp
attenu
detriment
effect
rsv
infect
epitheli
barrier
includ
increas
permeabl
ion
larg
noncharg
tracer
well
tj
aj
disassembl
fig
interestingli
barrierprotect
effect
observ
camp
elev
either
prevent
mode
onset
rsv
infect
therapeut
mode
sever
hour
initi
viral
infect
fig
latter
observ
especi
import
rais
attract
possibl
use
campelev
drug
stabil
respiratori
barrier
limit
airway
inflamm
rsvinfect
patient
camppka
signal
previous
implic
regul
epitheli
endotheli
barrier
barrierstabil
destabil
role
signal
describ
studi
also
provid
insight
mechan
camp
protect
epitheli
barrier
infect
cell
monolay
specif
identifi
pka
key
downstream
effector
camp
action
conclus
base
biochem
evid
pka
activ
phosphoryl
nuclear
transloc
creb
fig
forskolintr
epitheli
cell
well
rule
involv
altern
camp
effector
epac
fig
addit
pka
inhibit
block
forskolininduc
phosphoryl
creb
revers
stabil
effect
forskolin
apic
junction
rsvtreat
bronchial
cell
monolay
fig
pka
phosphoryl
larg
number
target
includ
adhes
cytoskelet
signal
protein
differ
subset
protein
subject
pka
regul
differ
experiment
condit
pka
activ
one
sever
signal
event
trigger
rsv
infect
addit
rsv
known
induc
activ
signal
pathway
famili
transcript
factor
regul
wide
array
gene
particularli
involv
immun
respons
relationship
camp
complex
depend
cell
type
treatment
paper
use
epitheli
cell
report
camp
inhibit
activ
howev
studi
shown
either
enhanc
constant
activ
camp
induc
data
suggest
actin
cytoskeleton
involv
observ
barrierprotect
effect
camppka
signal
airway
epitheli
cell
inde
tj
aj
known
associ
cortic
factin
bundl
associ
import
stabil
tj
aj
structur
steadyst
epitheli
cell
monolay
furthermor
remodel
perijunct
actin
cytoskeleton
drive
ajc
disassembl
barrier
disrupt
tissu
inflamm
present
studi
fig
along
previou
public
demonstr
rsv
infect
trigger
reorgan
perijunct
factin
parallel
remodel
apic
junction
airway
epitheli
cell
monolay
sinc
rsv
affect
express
ajc
protein
believ
impair
assembl
stabil
ajc
trigger
rearrang
perijunct
actin
cytoskeleton
reorgan
actin
like
involv
alter
dynam
polymer
depolymer
actin
filament
sinc
rsv
infect
also
alter
local
fig
phosphoryl
statu
import
regul
factin
dynam
cortactin
cortactin
ubiquit
express
actinbind
protein
mediat
factin
dynam
promot
filament
polymer
although
role
cortactin
regul
airway
epitheli
junction
studi
protein
known
local
endotheli
junction
campdepend
fashion
immunofluoresc
label
perform
present
studi
demonstr
diffus
cortic
local
cortactin
control
epitheli
cell
transloc
cortactin
later
plasma
membran
rsvtreat
cell
also
note
increas
coloc
cortactin
peripher
factin
bundl
follow
rsv
infect
may
indic
cortactindepend
remodel
actin
cytoskeleton
destabil
apic
junction
complex
note
describ
cytoskelet
remodel
cortactin
reloc
rsvinfect
epitheli
cell
like
associ
syncytium
format
sinc
chang
promin
larg
multinucl
cell
fig
exact
mechan
underli
pkadepend
regul
actin
cytoskeleton
remain
poorli
understood
yet
sever
scenario
envis
one
scenario
involv
direct
pkadepend
phosphoryl
differ
actinbind
protein
exampl
pka
target
vasodilatorstimul
phosphoprotein
elong
actin
filament
alphaadducin
cap
bundl
actin
filament
anoth
scenario
involv
indirect
effect
pka
actin
filament
dynam
modul
activ
small
gtpase
inde
pka
known
control
activ
rhoa
critic
regul
perijunct
actin
cytoskeleton
studi
requir
determin
exact
mechan
underli
protect
effect
camppka
signal
actin
cytoskeleton
apic
junction
rsvinfect
airway
epitheli
cell
pathophysiolog
implic
rsvinduc
airway
epitheli
barrier
dysfunct
well
understood
epidemiolog
studi
repeatedli
shown
associ
rsv
infect
subsequ
recurr
wheez
chronic
airway
inflamm
studi
indic
ecadherin
level
asthmat
patient
sputum
correl
asthma
sever
loss
catenin
aj
protein
intestin
epitheli
cell
associ
increas
mucos
inflamm
intestin
bleed
therefor
import
consequ
disrupt
integr
airway
epitheli
barrier
could
increas
tissu
inflamm
dysfunct
epitheli
barrier
would
like
enhanc
permeabl
allergen
particl
could
encount
dendrit
cell
immun
cell
result
initi
immun
respons
inflamm
could
exacerb
ajc
dysfunct
therefor
result
viciou
cycl
airway
addit
viral
infect
long
known
increas
suscept
infect
pathogen
evid
treatment
influenza
infect
oral
neuraminidas
prevent
mortal
secondari
bacteri
infect
therefor
anoth
implic
disrupt
epitheli
barrier
function
could
facilit
bacteri
transloc
across
epitheli
monolay
result
secondari
infect
anoth
import
find
studi
increas
camp
level
inhibit
express
rsv
f
protein
viral
propag
airway
epitheli
cell
monolay
fig
rsv
rna
viru
contain
gene
encod
protein
includ
f
protein
promot
syncytia
format
import
viral
replic
cycl
studi
suggest
elev
intracellular
camp
level
decreas
rsv
f
mrna
syncytia
format
particularli
import
studi
shown
degre
viral
load
play
critic
role
diseas
sever
other
report
viral
load
correl
rsv
diseas
sever
mous
model
rsv
infect
viral
load
respiratori
tract
directli
correl
system
chemocytokin
respons
airway
inflamm
respiratori
function
furthermor
devincenzo
et
al
show
natur
infect
infant
healthi
adult
volunt
rsv
rna
load
associ
diseas
sever
reason
suggest
inhibit
viral
biogenesi
contribut
observ
barrierstabil
effect
camp
howev
mechan
camp
action
given
fact
signal
messeng
also
protect
epitheli
ajc
disrupt
polyi
c
viral
replicationindepend
fashion
fig
studi
potenti
effect
camp
activ
viral
replic
exampl
activ
either
camppka
signal
shown
inhibit
replic
celltocel
transfer
pretreat
camp
analog
rat
oligodendrocyt
inhibit
replic
jhm
viru
hand
select
inhibit
epac
significantli
reduc
suscept
middl
east
respiratori
syndrom
coronaviru
merscov
infect
furthermor
replic
mammari
tumor
viruslik
particl
stimul
camp
wherea
replic
adenoviru
either
inhibit
stimul
camp
overal
present
studi
describ
public
highlight
camp
potent
modul
viral
infect
differ
tissu
organ
summari
studi
provid
compel
evid
camppkamedi
protect
rsvinduc
disrupt
model
airway
epitheli
barrier
strike
find
multipl
target
camp
action
infect
epithelium
includ
stabil
ajc
inhibit
rsv
propag
furthermor
antivir
barrierprotect
function
camp
effici
execut
differ
stage
rsv
infect
includ
late
stage
rsv
propag
within
epithelium
scientif
insight
gain
data
like
guid
design
futur
therapeut
approach
treat
acut
chronic
sequela
rsv
infect
addit
futur
studi
plan
dissect
longterm
effect
rsvinduc
ajc
disrupt
persist
lung
inflamm
role
camp
signal
pathway
ultim
regard
camppka
signal
effect
vivo
model
rsv
infect
essenti
investig
role
mechan
viralinduc
disrupt
pulmonari
barrier
complex
physiolog
lung
rsv
major
caus
lower
respiratori
tract
infect
one
primari
reason
hospit
worldwid
effici
antivir
therapi
vaccin
manag
diseas
camp
signal
pathway
involv
regul
mani
essenti
cellular
process
differenti
epitheli
layer
sought
identifi
effect
rsv
integr
airway
epitheli
barrier
modul
effect
camp
signal
found
activ
camp
prevent
rsvinduc
airway
epitheli
barrier
dysfunct
furthermor
camp
activ
decreas
rsv
viral
titer
even
treatment
deliv
rsv
infect
find
provid
novel
insight
understand
epitheli
cell
respons
clinic
signific
viru
poorli
defin
pathogenesi
limit
treatment
option
